The main purpose of this legislation, known as the "Right Drug Dose Now Act of 2025," is to enhance the National Action Plan for Adverse Drug Event Prevention. It aims to incorporate recent advancements in pharmacogenomic research and testing, which studies how genes affect a person's response to drugs. The goal is to improve patient safety by reducing adverse drug events through better understanding and use of genetic information in prescribing medications. Key provisions of the Act include several important actions.